[EN] SUBSTITUTED PYRROLOPYRIMIDINES AS HDM2 INHIBITORS<br/>[FR] PYRROLOPYRIMIDINES SUBSTITUÉES EN TANT QU'INHIBITEURS DE HDM2
申请人:MERCK SHARP & DOHME
公开号:WO2014100071A2
公开(公告)日:2014-06-26
The present invention provides substituted pyrrolopyrimidines as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.